$DRMA
Dermata Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
DRMA chart
What traders are saying about $DRMA
Latest postsDermata Therapeutics, Inc. news
- Dermata Therapeutics, Inc. (DRMA) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Dermata Therapeutics Highlights Media Recognition of Tome Skincare Following Commercial Launch
Yahoo Finance ·
- Dermata Advances Second Tome Skincare Product Toward Expected 2027 Launch with Initiation of Acne Clinical Trial
Yahoo Finance ·
- BC-Most Active Stocks
Yahoo Finance ·
- Dermata Therapeutics Announces Positive Topline Results from Cosmetic Study Evaluating Its Tome Foundational Treatment
Yahoo Finance ·
- Papulopustular Rosacea Market Report Now Available, Covers 11 Countries Across North America, Europe, and Asia-Pacific, Profiling Galderma, Journey Medical, Dermata Therapeutics, and Dr. Reddy's Laboratories
Yahoo Finance ·
- Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment
Yahoo Finance ·
- Dermata Announces Preorders Now Open for Tome Foundational Treatment Ahead of Commercial Launch
Yahoo Finance ·
- Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Yahoo Finance ·
- Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026
Yahoo Finance ·
- Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment
Yahoo Finance ·
- Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System
Yahoo Finance ·
Dermata Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$7.6M | -$12.3M | -$7.8M | -$9.6M |
| Diluted EPS | $-8.16 | $-80.32 | $-39.99 | – |
| Total assets (year end) | $7.9M | $3.5M | $8.0M | $6.9M |
| Cash and equivalents (year end) | $7.5M | $3.2M | – | $6.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Dermata Therapeutics, Inc.
- Ticker
- DRMA (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1853816
- Former names
- Dermata Therapeutics, Inc.
Frequently asked questions
What exchange is Dermata Therapeutics, Inc. listed on?
Dermata Therapeutics, Inc. trades on the Nasdaq under the ticker symbol DRMA.
What industry is Dermata Therapeutics, Inc. in?
Dermata Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Dermata Therapeutics, Inc. headquartered?
Dermata Therapeutics, Inc.'s business address on file with the SEC is in San Diego, CA.
When does Dermata Therapeutics, Inc.'s fiscal year end?
Dermata Therapeutics, Inc.'s fiscal year ends on December 31.